drugset / Trial / NCT00804752

Vitamin D Treatment in Patients With Chronic Hepatitis C

NCT00804752

Summary

We hypothesize that patients with Ch.HCV have a low level of vitamin D, and that by raising their vitamin D levels by adding it to their standard treament of Pegylated Interferon and Ribavirin, there will be an increase in their sustained virological response.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin D Other / unclassified 1000 iu